facebook tracking

CDSCO

Guidance document on dossier based licensing of Drugs for uniform product licensing in the country


regulatory illustration
Regulatory update
Manufacturer   |   Source: CDSCO
Published On: 17-03-2026

Enforcement Date: 17 March, 2026
Guidance document on dossier based licensing of Drugs for uniform product licensing in the country

The CDSCO has issued a guidance document on dossier-based drug licensing that provides clear regulatory direction to promote uniform manufacturing license approvals across India. By outlining structured administrative and technical requirements and integrating them within the ONDLS platform, the document enhances transparency, efficiency, and regulatory consistency. It reflects regulatory consensus and supports a harmonized, nationwide approach to product licensing.


The guidance document issued by the Central Drugs Standard Control Organization (CDSCO) provides clear and structured direction on dossier-based licensing of drugs for manufacturing approvals across India. It emphasizes uniformity in regulatory practices by outlining standardized requirements for administrative and technical documentation through a detailed checklist. The division of information into Section/Parts - covering company details, product-specific technical data, and manufacturing requirements - helps applicants understand expectations more efficiently. The integration of this checklist into the Online National Drugs Licensing System (ONDLS) further streamlines the submission and review process, reducing ambiguity and improving transparency. The document also reflects collaborative regulatory intent, having been discussed and agreed upon with State and UT Licensing Authorities in principle. Overall, the guidance is practical, well-organized, and aimed at harmonizing licensing decisions nationwide, which is likely to enhance regulatory consistency, ease of compliance, and timely processing of manufacturing license applications.

Applicable For: Manufacturer
Reference Number: F. No. DC-DT-15011(11)/20/2026 Notification Link

Related Regulatory Updates

Contact us

Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.